Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996–2004

References

• Khouzam HR, Battista MA, Emes R, Ahles S. Psychoses in late life: evaluation and management of disorders seen in primary care. Geriatrics 2005;60:26–33
   PubMed Web of Science ®Google Scholar
• Masand P. Clinical effectiveness of atypical antipsychotics in elderly patients with psychosis. Eur Neuropsychopharmacol 2004;14(Suppl 4):S461–S469
   Google Scholar
• Hermann RC, Yang D, Ettner SL, et al. Prescription of anti-psychotic drugs by office-based physicians in the United States, 1989–1997. Psychiatr Serv 2002;53:425–30
   PubMed Web of Science ®Google Scholar
• Aparasu RR, Bhatara V, Gupta S. US national trends in the use of antipsychotics during office visits,1998–2002. Ann Clin Psychiatry 2005;17: 147–52
   Google Scholar
• Rapoport M, Mamdani M, Shulman KI, et al. Antipsychotic use in the elderly: shifting trends and increasing costs. Int J Geriatr Psychiatry 2005;20:749–53
   PubMed Web of Science ®Google Scholar
• Schneider LS, Tariot PN, Dagerman KS, et al.; CATIE-AD Study Group. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. New Engl J Med 2006;355:1525–38
   Google Scholar
• Lieberman JA, Stroup TS, McEvoy JP, et al.; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New Engl J Med 2005;353:1209–23
   Google Scholar
• Kuno E, Rothbard AB. Racial disparities in antipsychotic prescription patterns for patients with schizophrenia. Am J Psychiatry 2002;159:567–72
   PubMed Web of Science ®Google Scholar
• Kreyenbuhl J, Zito JM, Buchanan RW, et al. Racial disparity in the pharmacological management of schizophrenia. Schizophr Bull 2003;29:183–93
   PubMed Web of Science ®Google Scholar
• Opolka JL, Rascati KL, Brown CM, et al. Ethnic differences in use of antipsychotic medication among Texas Medicaid clients with schizophrenia. J Clin Psychiatry 2003;64:635–9
   PubMed Web of Science ®Google Scholar
• Luo RD, Belleti DA, Tran D, et al. National prescribing patterns in the management of extrapyramidal symptoms among patients with schizophrenia. Int J Psychiatry Med 2002;32:261–9
   PubMed Web of Science ®Google Scholar
• Herbeck DM, West JC, Ruditis I, et al. Variations in use of second-generation antipsychotic medication by race among adult psychiatric patients. Psychiatr Serv 2004;55:677–84
   PubMed Web of Science ®Google Scholar
• Copeland LA, Zeber JE, Valenstein M, Blow FC. Racial disparity in the use of atypical antipsychotic medications among veterans. Am J Psychiatry 2003;160:1817–22
   PubMed Web of Science ®Google Scholar
• Daumit GL, Crum RM, Guallar E, et al. Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States. Arch Gen Psychiatry 2003;60:121–8
   PubMed Web of Science ®Google Scholar
• Van Brunt DL, Gibson PJ, Ramsey JL, and Obenchain R. Outpatient use of major antipsychotic drugs in ambulatory care settings in the United States, 1997–2000. Med Gen Med 2003;5: 16
   Google Scholar
• Rochon PA, Stukel TA, Bronskill SE, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med 2007;167:676–83
   PubMed Web of Science ®Google Scholar
• Liperoti R, Mor V, Lapane KL, et al. The use of atypical antipsychotics in nursing homes. J Clin Psychiatry 2003;64:1106–12
   PubMed Web of Science ®Google Scholar
• Briesacher BA, Limcangco MR, Simoni-Wastila L, et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 2005;165:1280–5
   Google Scholar
• Cohen SB. Sample design of the 1996 Medical Expenditure Panel Survey Household Component. Agency for Health Care Policy and Research, Rockville, MD. Available at: http://www.meps.ahrq.gov/data_files/publications/mr2/mr2.shtml [accessed September 23, 2007]
   Google Scholar
• Medical Expenditure Panel Survey: Survey Background. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp [accessed September 23, 2007]
   Google Scholar
• Medical Expenditure Panel Survey: Survey Questionnaires -Household Component. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.meps.ahrq.gov/mepsweb/survey_comp/survey.jsp [accessed September 23, 2007]
   Google Scholar
• Moeller JF, Stagnitti MN, Horan E. Outpatient prescription drugs: data collection and editing in the 1996 Medical Expenditure Survey (HC-010A) Rockville (MD). Agency for Health Care Policy and Research; 2001. MEPS Methodology Report No. 12. AHRQ Pub. No. 01–0002
   Google Scholar
• Machlin S, Yu W, Zodet M. Computing standard errors for MEPS estimates. January 2005. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.meps.ahrq.gov/mepsweb/survey_comp/standard_errors.jsp [accessed September 23, 2007]
   Google Scholar
• MEPS Household Component Weighting & Estimation Issues Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.meps.ahrq.gov/mepsweb/about_meps/workbook/WB-Weight_Estimat.pdf [accessed September 23, 2007]
   Google Scholar
• Cerner Multum Lexicon Guide Available at http://www.multum.com/LexGuide.pdf [accessed September 23, 2007]
   Google Scholar
• SAS 9.1. SAS Institute Inc, Cary, North Carolina
   Google Scholar
• SUDAAN 7.5. Research Triangle Institute, Research Triangle Park, North Carolina
   Google Scholar
• Andersen RM. A behavioral model of families’ use of health services [Research Series 25]. Center for Health Administration Studies, University of Chicago: Chicago; 1968
   Google Scholar
• Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 1995;36:1–10
   PubMed Web of Science ®Google Scholar
• Bagnall AM, Jones L, Ginnelly L, et al. A systematic review of atypical antipsychotic drugs in schizophrenia. Health Technol Assess 2003;7:1–193
   PubMedGoogle Scholar
• Deaths with antipsychotics in elderly patients with behavioral disturbances. FDA public health advisory. Available at: http://www.fda.gov/cder/drug/advisory/antipsychotics.htm [accessed September 23, 2007]
   Google Scholar
• Jin H, Meyer JM, Jeste DV. Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res 2004;71:195–212
   Google Scholar
• Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol 2000;29:722–9
   PubMed Web of Science ®Google Scholar
• Martens EP, Pestman WR, de Boer A, et al. Instrumental variables: application and limitations. Epidemiology 2006;17:260–7
   PubMed Web of Science ®Google Scholar
• Crown WH. Antidepressant selection and economic outcome: a review of methods and studies from clinical practice. Br J Psychiatry Suppl 2001;42:S18–S22
   Google Scholar
• Chung S. Does the use of SSRIs reduce medical care utilization and expenditures? J Ment Health Policy Econ 2005;8:119–29
   PubMed Web of Science ®Google Scholar